Wingstop: Q2 Earnings Insights

  Wingstop (NASDAQ:WING) reported its Q2 earnings results on Thursday, July 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

 

Wingstop (NASDAQ:WING) reported its Q2 earnings results on Thursday, July 28, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Wingstop beat estimated earnings by 25.0%, reporting an EPS of $0.45 versus an estimate of $0.36.

Revenue was up $9.78 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 9.32% drop in the share price the next day.

Here’s a look at Wingstop’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.40 0.31 0.35 0.33
EPS Actual 0.34 0.24 0.29 0.38
Revenue Estimate 85.59M 73.53M 74.50M 73.13M
Revenue Actual 76.20M 72.03M 65.78M 74.00M

To track all earnings releases for Wingstop visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Wells Fargo Analyst Sees Opportunity For Homebuilding & Building Product Companies Amid Volatility: The Details

Wells Fargo analyst Sam Reid initiated coverage on several homebuilding and building products stocks. The analyst said recent volatility in the homebuilding space offers an opportunity. Reid cites that the high rates pose a barrier for resales but offer interesting TAM implications amid low existing home sales (EHS) builders. 

DHI

Read More

Dyadic’s C1 Platform Selected By The Vaccine And Immunotherapy Center At Massachusetts General Hospital As Part Of VIC’s $5.88M Award By U.S. DoD To Develop A Self-Assembling Vaccine Platform For Rapid Production Of Prophylactic Vaccines

Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein

DYAI